Clinical Trial Update: Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and efficacy results for KH902 administered through multiple injections in patients with diabetic macular edema during…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• KH902

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED